Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to 177Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice-Reference-Cited by-同舟云学术

Molecular Targeting Radiotherapy with Cyclo-RGDfK(C) Peptides Conjugated to 177Lu-Labeled Gold Nanoparticles in Tumor-Bearing Mice

Published:2014-03-01 Issue:3 Volume:10 Page:393-404
ISSN:1550-7033
Container-title:Journal of Biomedical Nanotechnology
language:en
Short-container-title:j biomed nanotechnol

Author:

Vilchis-Juárez Andrea,Ferro-Flores Guillermina,Santos-Cuevas Clara,Morales-Avila Enrique,Ocampo-García Blanca,Díaz-Nieto Lorenza,Luna-Gutiérrez Myrna,Jiménez-Mancilla Nallely,Pedraza-López Martha,Gómez-Oliván Leobardo

Publisher

American Scientific Publishers

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies;Journal of Drug Delivery Science and Technology;2024-10

2. In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer;Pharmaceuticals;2024-06-05

3. Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape;EJNMMI Radiopharmacy and Chemistry;2024-05-04

4. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

5. In Vitro Assessment of 177Lu-labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the treatment of HER2-Positive Breast Cancer;2023-11-08